NMR crystallography: Imaging active site chemistry and protonation states

NMR 晶体学：对活性位点化学和质子化状态进行成像

• 批准号: 10406831
• 负责人: Leonard J Mueller
• 金额: $ 37.82万
• 依托单位: UNIVERSITY OF CALIFORNIA RIVERSIDE
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-08-01 至 2027-07-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10406831
• 关键词: Acids; Active Sites; Amines; Antibiotic Resistance; Antibiotics; Antidiabetic Drugs; Antimalarials; Cephalosporins; Charge; Chemicals; Chemistry; Crystallography; Decarboxylation; Disease; Drug Design; Enzymes; Family; Goals; Health; Hydrogen; Hydrogen Bonding; Image; Investigation; Link; Measures; Mediating; Metachromatic Leukodystrophy; Modeling; Molecular; Monobactams; Neutrons; Parkinson Disease; Penicillins; Pharmaceutical Preparations; Positioning Attribute; Pyridoxal Phosphate; Reaction; Resolution; Structure; System; Techniques; Therapeutic; Tryptophan Synthase; Tuberculosis; Vitamin B6; Work; X-Ray Crystallography; amino acid metabolism; amino group; base; benzimidazole; beta-Lactam Resistance; beta-Lactamase; cofactor; computational chemistry; covalent bond; enzyme mechanism; experimental study; improved; inhibitor; novel; peer; protonation; racemization; rational design; restraint; solid state nuclear magnetic resonance; success; transamination

My group is working to develop NMR-assisted crystallography – the synergistic combination of solid-state nuclear magnetic resonance, X-ray crystallography, and computational chemistry – as an atomic-resolution probe of enzyme active sites, capable of defining the position of all atoms, including hydrogens. By locating hydrogen atoms, this technique provides the often critical missing chemical information necessary to link structure and mechanism, as well as providing crucial information for the rational design of therapeutics. The approach is three-fold: X-ray crystallography is used to provide a coarse structural framework upon which chemically-detailed models of the active site are built using computational chemistry, and various active site chemistries explored; these models can be quantitatively distinguished by comparing their predicted NMR chemical shifts with the results from solid-state NMR experiments. Provided a sufficient number of chemical shift restraints are measured within the active site, NMR-assisted crystallography can uniquely identify the structure. The targeted systems include pyridoxal-5’-phosphate (PLP)-dependent enzymes, which have been implicated in numerous health conditions and as targets for treating diseases, and the β-Lactamases, which mediate antibiotic resistance to β-lactam antibiotics. The family of PLP-dependent enzymes are involved in the metabolism of amino acids and other amine- containing biomolecules. This single cofactor can participate in a diverse array of chemical transformations, including racemization, transamination, α/β-decarboxylation, and α/β/γ- elimination and substitution. Understanding how active sites fine-tune the same cofactor for such varied reactions is a primary objective of this proposal. To accomplish this understanding, NMR-assisted crystallography is employed to characterize these enzymatic transformations with atomic resolution. In tryptophan synthase, this allows us to peer along the reaction coordinates into and out of multiple intermediates. Here the protonation states complete the chemical picture for why, for example, specific inhibitors such as benzimidazole are unable to react to form a covalent bond as it is held in the wrong orientation by hydrogen bonds to βGlu109 and the charged ε-amino group of βLys87. A second goal is to extend the successes in characterizing enzymatic transformations in PLP-dependent enzymes to the β-lactamases, starting with the Toho-1 β-lactamase. Here we build on our initial chemical shift assignments and characterization of dynamics in solution to study the chemical mechanism used to inhibit antibiotics. In this application, NMR-assisted crystallography will be developed at the interface with neutron crystallography, which to date has been unable to solve the structure in the presence of an inhibitor, but where understanding the mechanism at the chemical level requires that we assign the protonation states of the key active site acid/base catalytic residues.

我的团队正致力于发展核磁共振辅助晶体学——协同结合